Xu J - Search Results

1

Synbindin in extracellular signal-regulated protein kinase spatial regulation and gastric cancer aggressiveness.

Kong X, Qian J, Chen LS, Wang YC, Wang JL, Chen H, Weng YR, Zhao SL, Hong J, Chen YX, Zou W, Xu J, Fang JY. Kong X, et al. Among authors: xu j. J Natl Cancer Inst. 2013 Nov 20;105(22):1738-49. doi: 10.1093/jnci/djt271. Epub 2013 Oct 8. J Natl Cancer Inst. 2013. PMID: 24104608 Free PMC article.

2

OCT1 is a determinant of synbindin-related ERK signalling with independent prognostic significance in gastric cancer.

Qian J, Kong X, Deng N, Tan P, Chen H, Wang J, Li Z, Hu Y, Zou W, Xu J, Fang JY. Qian J, et al. Among authors: xu j. Gut. 2015 Jan;64(1):37-48. doi: 10.1136/gutjnl-2013-306584. Epub 2014 Apr 9. Gut. 2015. PMID: 24717932 Free PMC article.

3

TMEFF2 deregulation contributes to gastric carcinogenesis and indicates poor survival outcome.

Sun T, Du W, Xiong H, Yu Y, Weng Y, Ren L, Zhao H, Wang Y, Chen Y, Xu J, Xiang Y, Qin W, Cao W, Zou W, Chen H, Hong J, Fang JY. Sun T, et al. Among authors: xu j. Clin Cancer Res. 2014 Sep 1;20(17):4689-704. doi: 10.1158/1078-0432.CCR-14-0315. Epub 2014 Jul 1. Clin Cancer Res. 2014. PMID: 24987055

4

Long noncoding RNA GAPLINC regulates CD44-dependent cell invasiveness and associates with poor prognosis of gastric cancer.

Hu Y, Wang J, Qian J, Kong X, Tang J, Wang Y, Chen H, Hong J, Zou W, Chen Y, Xu J, Fang JY. Hu Y, et al. Among authors: xu j. Cancer Res. 2014 Dec 1;74(23):6890-902. doi: 10.1158/0008-5472.CAN-14-0686. Epub 2014 Oct 2. Cancer Res. 2014. PMID: 25277524

5

Upregulation of ASAP3 contributes to colorectal carcinogenesis and indicates poor survival outcome.

Tian H, Qian J, Ai L, Li Y, Su W, Kong XM, Xu J, Fang JY. Tian H, et al. Among authors: xu j. Cancer Sci. 2017 Aug;108(8):1544-1555. doi: 10.1111/cas.13281. Epub 2017 Jun 14. Cancer Sci. 2017. PMID: 28502111 Free PMC article.

6

Synbindin deficiency inhibits colon carcinogenesis by attenuating Wnt cascade and balancing gut microbiome.

Ai L, Ren Y, Li Y, Chen H, Qian Y, Lu S, Xu A, Ren L, Zhao S, Chen Z, Chen YX, Xu J, Fang JY. Ai L, et al. Among authors: xu a, xu j. Int J Cancer. 2019 Jul 1;145(1):206-220. doi: 10.1002/ijc.32074. Epub 2019 Jan 10. Int J Cancer. 2019. PMID: 30561033

7

Colorectal cancer cells refractory to anti-VEGF treatment are vulnerable to glycolytic blockade due to persistent impairment of mitochondria.

Xu J, Wang J, Xu B, Ge H, Zhou X, Fang JY. Xu J, et al. Among authors: xu b. Mol Cancer Ther. 2013 May;12(5):717-24. doi: 10.1158/1535-7163.MCT-12-1016-T. Epub 2013 Feb 20. Mol Cancer Ther. 2013. PMID: 23427299

8

Candidate microRNA biomarkers in human gastric cancer: a systematic review and validation study.

Wang JL, Hu Y, Kong X, Wang ZH, Chen HY, Xu J, Fang JY. Wang JL, et al. Among authors: xu j. PLoS One. 2013 Sep 9;8(9):e73683. doi: 10.1371/journal.pone.0073683. eCollection 2013. PLoS One. 2013. PMID: 24040025 Free PMC article. Review.

9

Combined PTEN Mutation and Protein Expression Associate with Overall and Disease-Free Survival of Glioblastoma Patients.

Xu J, Li Z, Wang J, Chen H, Fang JY. Xu J, et al. Transl Oncol. 2014 Apr;7(2):196-205.e1. doi: 10.1016/j.tranon.2014.02.004. Epub 2014 Mar 4. Transl Oncol. 2014. PMID: 24721394 Free PMC article.

10

A long non-coding RNA signature to improve prognosis prediction of colorectal cancer.

Hu Y, Chen HY, Yu CY, Xu J, Wang JL, Qian J, Zhang X, Fang JY. Hu Y, et al. Among authors: xu j. Oncotarget. 2014 Apr 30;5(8):2230-42. doi: 10.18632/oncotarget.1895. Oncotarget. 2014. PMID: 24809982 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66,912 results

Search Page

Filters